GERALDINE CABERO: Open Payments
NPI 1700314895 · MATTAWA, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$784 in 29 payments from 14 companies in 2025. Trend: 2023 $1,870 · 2024 $1,160 · 2025 $784
Food & beverage: $685Education: $99
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $166 |
| Janssen Biotech, Inc. | 5 | $143 |
| GENZYME CORPORATION | 4 | $113 |
| Regeneron Healthcare Solutions, Inc. | 4 | $101 |
| PFIZER INC. | 1 | $58 |
| UCB, Inc. | 1 | $35 |
| Incyte Corporation | 1 | $28 |
| Lilly USA, LLC | 1 | $28 |
| Amgen Inc. | 1 | $28 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $22 |
Products named: DUPIXENT, TREMFYA, BOTOX, SKYRIZI, LITFULO, Bimzelx, LIBTAYO, OPZELURA.
Industry payments across WA — which companies pay providers there.
